You are here: Home » Markets » News
Business Standard

Ami Organics, Vijaya Diagnostic make strong stock market debuts

Ami Organics' stock closed at Rs 935, with a gain of Rs 325, while Vijaya Diagnostic finished at Rs 619, with a gain of Rs 88.

Topics
stock market | listing

Sundar Sethuraman  |  Mumbai 

Ashish Chauhan, MD&CEO, BSE India presenting a memento Shri Nareshkumar Ramjibhai Patel, Executive Chairman and MD, Ami Organics Limited and other senior officials at the listing ceremony
Ashish Chauhan, MD&CEO, BSE India presenting a memento Shri Nareshkumar Ramjibhai Patel, Executive Chairman and MD, Ami Organics Limited and other senior officials at the listing ceremony

Shares of Ami Organics and Vijaya Diagnostic rallied 53 per cent and 17 per cent over their issue price during their debut on Tuesday.

Ami Organics’ stock closed at Rs 935, with a gain of Rs 325, while Vijaya Diagnostic finished at Rs 619, with a gain of Rs 88.

Ami Organics’ initial public offering (IPO) was subscribed 65 times. Its IPO consisted of Rs 200-crore fresh fund raise and Rs 370-crore secondary share sale.

Vijaya Diagnostic, one of the largest diagnostic chains in southern India, garnered 4.5 times subscription for its IPO. The IPO was entirely a secondary share sale worth Rs 1,894 crore.

The gains made by Ami Organics and Vijaya Diagnostic end the succession of tepid listings in the recent past. Shares of the previous four companies to make their debut had dropped below their IPO price on day.

So far, till August 2021, companies have raised Rs 60,288 crore through IPOs, the highest since 2017.

Sansera Engineering IPO subscribed 53% on day1

Sansera Engineering’s IPO was subscribed 53 per cent on Tuesday, the first day of the issue.

A day earlier, the auto component maker had allotted shares worth Rs 382 crore to anchor investors at Rs 744 per share. Sansera has priced its issue between Rs 734 and Rs 744 per share. Sansera’s IPO is entirely an offer for sale worth Rs 1,283 crore. At the top-end of the price band, the company’s market cap translates to Rs 3,823 crore. “At Rs 744, FY21 P/E of 35 times appears reasonable given the expected improvement in earnings CAGR over FY21-23 and hence we recommend subscribe,” AngelOne said in a note.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, September 14 2021. 17:35 IST
RECOMMENDED FOR YOU
.